Filing Details

Accession Number:
0001181431-12-029998
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-15 13:00:00
Reporting Period:
2012-05-14
Filing Date:
2012-05-15
Accepted Time:
2012-05-15 17:12:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527573 H. Eric Siegel Experimental Station
Route 141 And Henry Clay Rd
Wilmington DE 19880
Evp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-14 8,002 $16.66 8,817 No 4 M Direct
Common Stock Acquisiton 2012-05-14 31,997 $16.66 40,814 No 4 M Direct
Common Stock Acquisiton 2012-05-14 16,667 $14.72 57,481 No 4 M Direct
Common Stock Disposition 2012-05-14 56,666 $23.12 815 No 4 S Direct
Common Stock Disposition 2012-05-14 100 $23.12 715 No 4 S Direct
Common Stock Disposition 2012-05-14 715 $23.11 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-05-14 8,002 $0.00 8,002 $16.66
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-05-14 31,997 $0.00 31,997 $16.66
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-05-14 16,667 $0.00 16,667 $14.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,004 2017-10-28 No 4 M Direct
29,997 2017-10-28 No 4 M Direct
22,221 2018-01-24 No 4 M Direct
Footnotes
  1. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  2. Represents weighted average sale price. Actual sale prices ranged from $23.05 to $23.15.
  3. Beginning October 29, 2010, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years.
  4. Beginning January 25, 2011, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years.